Heart & blood pressure · Washington area, DC
Heart and blood pressure studies in Washington area, DC
10 recruiting studies have a site in the Washington area. This page includes nearby cities such as Bethesda, Rockville, Silver Spring, Gaithersburg.
10 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- Washington D.C., DC + 58 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals
- Location
- Washington D.C., DC + 40 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca
- Location
- Washington D.C., DC + 104 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- Washington D.C., DC + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Washington D.C., DC + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Washington D.C., DC + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Washington D.C., DC + 36 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingHealthy volunteers
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 1–100
- RecruitingHealthy volunteers
Technical Development of Cardiovascular Magnetic Resonance Imaging
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 12–25
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.